These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9927228)

  • 21. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".
    Micheletti MC; Chevallier T
    Circulation; 2007 Sep; 116(13):e362; author reply e363. PubMed ID: 17893283
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormonal therapy with patch or pill: how much does it matter?
    Schaudig K; Thomssen C
    Thromb Haemost; 2007 Apr; 97(4):503-4. PubMed ID: 17393010
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
    Scarabin PY; Oger E; Plu-Bureau G;
    Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thrombosis and conjugated equine estrogen in women without a uterus.
    Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
    Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
    Rosendaal FR
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
    Odem RR; Moniz MH; Allsworth JE; Bleckman CR; Omicioli VA; Lawrence LT; Thaker PH
    Am J Obstet Gynecol; 2007 Aug; 197(2):213-4; discussion e1-5. PubMed ID: 17689656
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.
    Pérez Gutthann S; García Rodríguez LA; Castellsague J; Duque Oliart A
    BMJ; 1997 Mar; 314(7083):796-800. PubMed ID: 9081000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type of hormone replacement therapy and risk of venous thromboembolism.
    Roberts H
    BMJ; 2008 May; 336(7655):1203-4. PubMed ID: 18495630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence and risk factors for venous thromboembolism].
    Oger E; Mottier D
    Rev Prat; 2007 Apr; 57(7):711-3, 716, 719-20. PubMed ID: 17626316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy to reduce cardiovascular risk: a concept whose time has passed?
    Alpert MA
    South Med J; 2002 Sep; 95(9):959-61. PubMed ID: 12356133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.